Skip to main content
. 2021 Nov 23;10(4):300–306. doi: 10.1007/s13668-021-00375-z

Table 1.

Reported prevalence of gastrointestinal symptoms associated with SARS-CoV-2 infection

Gastrointestinal symptoms associated with SARS-CoV-2 infection
Loss of appetite 21% (range 1–79%)
Liver injury 19% (range 1–53%)
Diarrhea 9% (range 1–34%)
Nausea or vomiting 6% (range 1–19%)
Abdominal pain 3% (range 1–4%)

Ref. Mao R, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2020;5(7):667–78